This article is more than 5 years old. Information may no longer be current.

AAD app for psoriasis, psoriatic arthritis now available

MIAMI BEACH, Fla. — The American Academy of Dermatology has introduced a mobile app of evidence-based clinical guidelines for diagnosing and treating psoriasis and psoriatic arthritis, it announced today at its annual meeting.

The free app is available at www.aad.org/PsoriasisApp and includes a clinical decision tree; reference guide for diagnoses; arthritic diagnostic checklist and scoring; clinical recommendations for all available therapies; a guide to topical therapy and methotrexate treatment, phototherapy/photochemotherapy dosing guidelines; CPT and HCPCS codes and a treatment reimbursement algorithm; and case studies and treatment algorithm.

“Psoriasis is a complex skin condition that requires proper evaluation, a customized treatment approach and regular monitoring,” AAD President Daniel M. Siegel, MD, FAAD, said in a press release. “This new app is a valuable resource that will aid dermatologists and all clinicians with its easy-to-use recommendations and treatment algorithms for psoriasis and psoriatic arthritis.”

The guidelines were published in the Journal of the American Academy of Dermatology from 2008 to 2011 and assessed available therapies for psoriasis based on scientific literature review. The four major therapeutic areas for psoriasis — biologics, topical therapies, traditional systemic agents, and phototherapy and photochemotherapy — and the treatment of psoriatic arthritis were the focus of the guidelines.